Jeffry R Borgmeyer

Title: Jeffry R Borgmeyer: Innovator in Antibody Drug Conjugate Purification

Introduction

Jeffry R Borgmeyer is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of antibody drug conjugates. His innovative work has the potential to enhance the efficacy and safety of therapeutic agents.

Latest Patents

Jeffry holds a patent for the "Purification of antibody drug conjugates using a sodium phosphate gradient." This patent details methods for removing high molecular weight species, specifically aggregates, from antibody drug conjugate preparations. The process involves contacting preparations of the antibody drug conjugate reaction mixture with a hydroxyapatite resin and selectively eluting the ADC from the resin using a sodium phosphate gradient.

Career Highlights

Jeffry is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer focuses on advancing drug development processes and improving therapeutic outcomes through innovative purification techniques.

Collaborations

Throughout his career, Jeffry has collaborated with esteemed colleagues, including Durgesh Vasant Nadkarni and He Meng. These collaborations have fostered a productive environment for research and development in the field of antibody drug conjugates.

Conclusion

Jeffry R Borgmeyer is a distinguished inventor whose work in antibody drug conjugate purification is paving the way for advancements in biopharmaceuticals. His contributions are vital for the future of therapeutic development and patient care.